CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Abbott [NYSE:ABT]

Dr. Nick West, Chief Medical Officer

Combining skill with intelligent diagnostics is a recipe for better patient outcomes

Dr. Nick West

Dr. Nick West

Entrusting technology to help arrive at a treatment plan for your patients can be a big leap of faith for some physicians: for those who have always relied on their training, experience, and intuition to make clinical decisions, choosing to rely on telemedicine for a virtual assessment that will determine a clinical pathway is diametrically opposed to everything they have ever known or practiced.


At medical school we are taught about the importance of face-to-face interaction, of asking questions about an individual’s symptoms and of laying hands upon them in order to determine what their medical issue might be, and to then choose appropriate, and preferably non-invasive, tests to achieve an accurate diagnosis. So why would anyone knowingly choose to deviate from what seems to be working?


One reason may be that patients are demanding more personalized care - they want a diagnostic and treatment pathway designed specifically for their needs, based on their history and background, their presentation and their particular set of symptoms and physical signs. The ‘one[1]size-fits-all’ model of healthcare delivery, driving patients down generic care pathways based on a physician’s ‘best guess’ is no longer meeting expectations of the patient population.


Other reasons to consider adopting emerging diagnostic technologies as part of one’s practice include achieving an accurate diagnosis whilst reducing the time to diagnosis, as well as limiting the need for more invasive techniques that are less convenient and often entail some risk.


So why the resistance to adoption of these technologies? There is an inherent suspicion in the physician community of any techniques that involve a black box (data goes in, a diagnosis comes out the other end), and many of the emerging consumer-facing technologies and even more complex diagnostic technologies are “black boxes.” Physicians like to know about the “why” and the “how.” Telling a physician that a machine is more accurate than they are isn’t always likely to win them over…


But what if you were to tell a physician that their expert opinion could be corroborated and augmented by a machine - in essence “sense-checking” their diagnosis?


The growing prominence of technologies that fall under this umbrella is steadily enabling more personalized care and is highly likely to lead to better patient outcomes. Innovations include everything from virtual visits, to wearables, use of data analytics with artificial intelligence/machine learning[1]derived algorithms and novel diagnostic approaches that might combine some or all of these aspects. 


The thing that all of these techniques have in common is that they are attempting to bridge the gap between symptom recognition (whether by patient or by physician) and somehow getting to a definitive diagnosis.


Right now, patients are becoming increasingly engaged in personally-directed, consumer-friendly devices that may be passively or actively monitoring activity and biometric indices, whether via smartphones or smart wearables such as watches, rings or other monitors, all of which can generate enormous amounts of data, blurring the boundaries between monitoring for wellness as opposed to strictly healthcare indications.


Such approaches also address the tricky issue of recall bias - we all know that none of us are good at remembering our symptoms with accuracy beyond a week or two at best, and intermittent consultations or even clinical-trial based questionnaires or assessments are unlikely to paint an accurate picture; monitoring devices, however, can provide continuous monitoring to obtain granular real-time data that is much more meaningful to a physician who is trying to either arrive at a diagnosis or conduct disease-state monitoring.


The same theory is true for imaging technologies that are now integrated with software platforms to automatically detect the things physicians need to know in order to make a decision, by streamlining the process, and crucially eliminating variability, which in turn improves quality of healthcare delivered and received. Imaging technologies can enable physicians to make a diagnosis when there is a lack of symptom recognition and a lack of information. When physicians need more sensitive and specific information, that’s where tools and technologies like imaging tools combined with intelligent software can have a meaningful impact, although these remain persistently underutilized simply because they are perceived to be more complex to execute.


Removing the barriers to use of these tools and technologies can make them more accessible to physicians. For example, virtual training using simulation tools, or VR goggles to allow self-paced teaching and training, both enable better levels of engagement. Software and user interfaces developed for newer tools such as intravascular imagingare now simpler to interpret with guided workflows and the use of algorithms that provide physicians with more accurate and actionable data to augment their own knowledge in devising an appropriate care plan.


Acceptance by both the public and the physician community of tools to monitor and drive better healthcare won’t happen overnight, but there is a growing acceptance of digital health tools holistically and that can only be a good thing.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://patient-recruitment.lifesciencesreview.com/leadership-perspective/combining-skill-with-intelligent-diagnostics-is-a-recipe-for-better-patient-outcomes-nwid-1168.html